Pharmaceutical Company Payments to Japanese Government Drug Regulation Committee Members-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmaceutical Company Payments to Japanese Government Drug Regulation Committee Members

Published:2020-06-15 Issue:5 Volume:108 Page:1049-1054
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Sawano Toyoaki¹,Ozaki Akihiko²,Saito Hiroaki³,Shimada Yuki⁴,Tanimoto Tetsuya²

Affiliation:

1. Department of Surgery Sendai City Medical Center Sendai Miyagi Japan

2. Medical Governance Research Institute Minato-ku Tokyo Japan

3. Department of Gastroenterology Sendai Kousei Hospital Sendai Miyagi Japan

4. Department of Neurosurgery Minamisoma Municipal General Hospital Fukushima Japan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1892

Reference21 articles.

1. Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry

2. Pharmaceutical Industry–Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries

3. Professional Medical Associations and Their Relationships With Industry

4. Addressing Bias and Conflict of Interest Among Biomedical Researchers

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency;Globalization and Health;2023-03-03

2. The Diovan scandal in Japan; don’t let bygones be bygones;Journal of Human Hypertension;2022-03-29

3. Awareness and Perceptions among Members of a Japanese Cancer Patient Advocacy Group Concerning the Financial Relationships between the Pharmaceutical Industry and Physicians;International Journal of Environmental Research and Public Health;2022-03-15

4. Funding of Clinical Trials Through Non-Profit and Third-Party Organizations: A Case Study of the CREATE-X Trial in Japan;Integrity of Scientific Research;2022

5. Awareness and perceptions among members of a Japanese cancer patient advocacy group concerning the financial relationships between the pharmaceutical industry and physicians: a mixed-methods analysis of survey data;2021-07-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3